EMVision Medical Devices Ltd (ASX:EMV)
Australia · Delayed Price · Currency is AUD 1.670
-0.055 (-3.19%)
Aug 28, 2026, 4:10 PM AEST
EMVision Medical Devices Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 17.1 | 10.46 | 18.6 | 9.89 | 6.8 |
Short-Term Investments | - | - | - | 0.01 | - |
Cash & Short-Term Investments | 17.1 | 10.46 | 18.6 | 9.9 | 6.8 |
Cash Growth | 63.57% | -43.79% | 87.89% | 45.61% | -29.83% |
Accounts Receivable | 4.3 | 3.14 | 2.8 | - | - |
Other Receivables | - | - | 0.12 | - | 0.07 |
Receivables | 4.3 | 3.14 | 2.92 | - | 0.07 |
Prepaid Expenses | - | - | 0.27 | 0.27 | 0.2 |
Other Current Assets | 0.3 | 0.35 | 0.08 | 0.07 | - |
Total Current Assets | 21.7 | 13.94 | 21.87 | 10.23 | 7.07 |
Property, Plant & Equipment | 0.78 | 1.03 | 0.52 | 0.8 | 0.96 |
Other Intangible Assets | 0.56 | 0.61 | 0.65 | 0.48 | 0.48 |
Long-Term Deferred Tax Assets | - | - | 0.93 | - | - |
Total Assets | 23.04 | 15.57 | 23.97 | 11.52 | 8.51 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 2.31 | 0.96 | 0.29 | 0.33 | 0.18 |
Accrued Expenses | 0.52 | 0.44 | 0.37 | 0.4 | 0.27 |
Short-Term Debt | - | - | 0.82 | 2.5 | - |
Current Portion of Leases | 0.27 | 0.21 | 0.25 | 0.23 | 0.2 |
Current Unearned Revenue | - | 0.87 | 1.05 | 2.3 | - |
Other Current Liabilities | - | 0.36 | 0.63 | 0.29 | 0.21 |
Total Current Liabilities | 3.92 | 2.84 | 3.41 | 6.04 | 0.85 |
Long-Term Debt | 2.74 | 2.65 | 1.77 | - | - |
Long-Term Leases | 0.4 | 0.67 | 0.06 | 0.31 | 0.54 |
Pension & Post-Retirement Benefits | 0.21 | 0.13 | 0.07 | 0.05 | - |
Long-Term Deferred Tax Liabilities | - | - | 0.14 | - | - |
Other Long-Term Liabilities | - | 0 | - | - | 0.03 |
Total Liabilities | 7.27 | 6.29 | 5.46 | 6.4 | 1.43 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 53.65 | 41.75 | 41.57 | 26.23 | 23.21 |
Retained Earnings | -41.17 | -34.82 | -26.52 | -25.66 | -21.79 |
Comprehensive Income & Other | 3.28 | 2.35 | 3.46 | 4.55 | 5.66 |
Shareholders' Equity | 15.77 | 9.28 | 18.52 | 5.12 | 7.08 |
Total Liabilities & Equity | 23.04 | 15.57 | 23.97 | 11.52 | 8.51 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 3.41 | 3.53 | 2.9 | 3.04 | 0.74 |
Net Cash (Debt) | 13.7 | 6.92 | 15.7 | 6.86 | 6.06 |
Net Cash Growth | 97.88% | -55.91% | 128.91% | 13.17% | -36.04% |
Net Cash Per Share | 0.15 | 0.08 | 0.20 | 0.09 | 0.08 |
Filing Date Shares Outstanding | 93.02 | 85.52 | 85.42 | 77.92 | 77.63 |
Total Common Shares Outstanding | 93.02 | 85.52 | 85.42 | 77.92 | 77.63 |
Working Capital | 17.77 | 11.1 | 18.45 | 4.2 | 6.21 |
Book Value Per Share | 0.17 | 0.11 | 0.22 | 0.07 | 0.09 |
Tangible Book Value | 15.21 | 8.68 | 17.86 | 4.64 | 6.6 |
Tangible Book Value Per Share | 0.16 | 0.10 | 0.21 | 0.06 | 0.09 |
Machinery | - | 0.67 | 0.62 | 0.51 | 0.32 |